We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 96 results
  1. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer

    Background

    Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer subtype often treated with radiotherapy (RT). Due to its...

    Sushmitha Sriramulu, Shivani Thoidingjam, ... Shyam Nyati in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 June 2024
  2. Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer

    Purpose of Review

    Castration-resistant prostate cancer (CRPC) is a lethal form of prostate cancer (PCa) due to the development of resistance to...

    Chandra Kishore, **aolin Zi in Current Pharmacology Reports
    Article 19 September 2023
  3. The DNA Damage Checkpoint

    The DNA damage response (DDR), also known as the DNA damage checkpoint (DNADC) acts to prevent cells with damaged DNA from entering mitosis. Kinds of...
    Chapter 2023
  4. DNA damage repair and cancer immunotherapy

    Cells are exposed to multiple endogenous and exogenous stresses daily, some of which can induce DNA damage, a major source of genomic instability. To...

    Zhiyuan **ang, Hao Liu, Ying Hu in Genome Instability & Disease
    Article 31 March 2023
  5. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375/PRKDC Axis and PD-L1 phosphorylation

    Background

    Targeted drugs are not quite effective for prolonging the survival of patients with gastric cancer due to off-target effects as well as...

    Zhenyan Miao, Jifei Li, ... Yingying **ng in Molecular Cancer
    Article Open access 13 December 2023
  6. Phase separation of low-complexity domains in cellular function and disease

    In this review, we discuss the ways in which recent studies of low-complexity (LC) domains have challenged our understanding of the mechanisms...

    Jiwon Lee, Hana Cho, Ilmin Kwon in Experimental & Molecular Medicine
    Article Open access 29 September 2022
  7. Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

    Endocrine therapy (ET) is an effective first-line therapy for women with estrogen receptor-positive (ER + ) breast cancers. While both ionizing...

    Anna R. Michmerhuizen, Lynn M. Lerner, ... Corey W. Speers in npj Breast Cancer
    Article Open access 10 March 2022
  8. Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

    Constant challenges for the treatment of mantle cell lymphoma (MCL) remain to be recurrent relapses and therapy resistance, especially in patients...

    Yuxuan Che, Yang Liu, ... Michael Wang in Blood Cancer Journal
    Article Open access 17 February 2023
  9. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes

    Background

    Prognosis of esophageal squamous cell carcinoma (ESCC) patients is poor and the concurrent chemoradiation therapy (CCRT) provided to ESCC...

    I-Ying Kuo, Yu-Lin Huang, ... Yi-Ching Wang in Journal of Biomedical Science
    Article Open access 18 February 2019
  10. Network Biology Approaches to Uncover Therapeutic Targets Associated with Molecular Signaling Pathways from circRNA in Postoperative Cognitive Dysfunction Pathogenesis

    Postoperative cognitive dysfunction (POCD) is a cognitive deterioration and dementia that arise after a surgical procedure, affecting up to 40% of...

    Piplu Bhuiyan, GS Chuwdhury, ... Yanning Qian in Journal of Molecular Neuroscience
    Article 06 July 2022
  11. The activation mechanisms of master kinases in the DNA damage response

    DNA damage can be introduced by intrinsic or extrinsic stimuli and threaten the transmission of genetic information and ultimately, survival....

    Jianxiong **ao, Qinhui Rao, Yanhui Xu in Genome Instability & Disease
    Article 30 June 2021
  12. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model

    Background

    The prognostic management of bladder cancer (BLCA) remains a great challenge for clinicians. Recently, bulk RNA-seq sequencing data have...

    Zhiyong Tan, **aorong Chen, ... Jiansong Wang in Journal of Translational Medicine
    Article Open access 27 March 2023
  13. Targeting the Transcription Factors of ROS Tumorigenic Pathways as a Therapeutic Strategy in Cancer

    Emerging of reactive oxygen species (ROS) on the earth with the first oxygen molecule in the atmosphere around 2.4–3.8 billion years ago, and they...
    Kannappan Sriramajayam, Ravindran Caspa Gokulan, Jayaraman Tharmalingam in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  14. Targeting the Transcription Factors of ROS Tumorigenic Pathways as a Therapeutic Strategy in Cancer

    Emerging of reactive oxygen species (ROS) on the earth with the first oxygen molecule in the atmosphere around 2.4–3.8 billion years ago, and they...
    Kannappan Sriramajayam, Ravindran Caspa Gokulan, Jayaraman Tharmalingam in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  15. ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer

    Background

    AZD0156 is an oral inhibitor of ATM, a serine threonine kinase that plays a key role in DNA damage response (DDR) associated with...

    S. Lindsey Davis, Sarah J. Hartman, ... Todd M. Pitts in BMC Cancer
    Article Open access 29 October 2022
  16. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target

    Background

    N-end rule ubiquitination pathway is known to be disrupted in many diseases, including cancer. UBR5, an E3 ubiquitin ligase, is mutated...

    Kumar Saurabh, Parag P. Shah, ... Levi J. Beverly in BMC Cancer
    Article Open access 31 August 2020
  17. Post-translational Mechanisms of Zinc Signalling in Cancer

    Three groups of proteins are actively involved in the control of intracellular zinc, consisting of ZIP channels (SLC39A), ZnT transporters (SLC30A),...
    Thirayost Nimmanon, Kathryn M. Taylor in Zinc Signaling
    Chapter 2019
  18. Telomeres, Telomerase, and Aging

    We present a list of basic functions to ensure viability of living systems and highlight the roles that telomerase plays. Telomere length is an...
    Deepak K. Mishra, Ramraj Prasad, Pramod Yadava in Models, Molecules and Mechanisms in Biogerontology
    Chapter 2020
  19. Heterogeneity of triple negative breast cancer: Current advances in subty** and treatment implications

    As the field of translational ‘omics has progressed, refined classifiers at both genomic and proteomic levels have emerged to decipher the...

    Karama Asleh, Nazia Riaz, Torsten O. Nielsen in Journal of Experimental & Clinical Cancer Research
    Article Open access 01 September 2022
  20. Targeting replication stress in cancer therapy

    Replication stress is a major cause of genomic instability and a crucial vulnerability of cancer cells. This vulnerability can be therapeutically...

    Alexandre André B. A. da Costa, Dipanjan Chowdhury, ... Panagiotis A. Konstantinopoulos in Nature Reviews Drug Discovery
    Article 06 October 2022
Did you find what you were looking for? Share feedback.